All filters
Slidesets
CPK/PD Support for a Phase 1 Study of TBA-7371- Jerry Nedelman, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Bedaquiline appears to antagonize its own main metabolite’s QTcF interval prolonging effect- Lénaïg Tanneau, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
TPreclinical and Clinical Pharmacokinetics and Pharmacodynamics Analysis of Delamanid- Suresh Mallikaarjun, PHD, FCP
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Translational pharmacokinetic modelling & simulation of an experimental long-acting injectable formulation of bedaquiline- An Vermeulen, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention- Anthony Podany, PharmD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Fluoroquinolones in the treatment of multidrug-resistant tuberculosis: experience from three US TB treatment centers- Charles Peloquin, PharmD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Clofazimine pharmacokinetics in South African patients with drug-resistant tuberculosis-Sean Wasserman, MBChB, MMed
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Pharmacokinetic-Pharmacodynamic Target Attainment Analysis of Cycloserine in TB Patients- Charles Peloquin, PharmD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Treatment of Multi-Drug Resistant TB- Robert Horsburgh, MD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
High peak rifampicin concentrations accelerate the slow phase of bacterial elimination in tuberculosis patients- Antal Martinecz
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Model-based meta-analysis of rifampicin exposure and mortality in phase II tuberculosis meningitis trials- Elin Svensson
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Pharmacodynamic Correlates of Linezolid Activity and Toxicity in a Mouse TB Model- Kristina Bigelow, MS
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Protein binding of rifampicin is not saturated when using high-dose rifampicin- Carlijn Litjens, MSc
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Using Mycobacterium tuberculosis single nucleotide polymorphisms to predict fluoroquinolone treatment response- Timothy Rodwell, MD PhD MPH
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Delamanid Central Nervous System Pharmacokinetics in Tuberculous Meningitis- Elizabeth Tucker, MD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Transmitted/Founder Virus-Like Variants are Archived in the Reservoir- Kelsie Brooks
Presented at:
International Workshop on HIV Transmission 2018
Slidesets
Genital Inflammation and PrEP effectiveness- Mckinnon Lyle ,PhD
Presented at:
International Workshop on HIV Transmission 2018